51 results
ARS
2024 FY
ABSI
Absci Corp
23 Apr 24
Annual report to shareholders
4:10pm
to design highly specific, safe therapeutics for a wide variety of disease targets less addressable by small molecules. Absci was founded on a technology … their corresponding antigens, offering new therapeutic targets, as well as the cognate binding partners, for further potential validation and optimization. AI
424B5
ABSI
Absci Corp
28 Feb 24
Prospectus supplement for primary offering
8:34am
pipeline: We aim to create therapeutic assets comprising our own internal program pipeline. With the ability to find targets and develop potential best … novel drug targets, discover optimal biotherapeutic candidates, and generate the cell lines to manufacture them in a single efficient process. We believe
8-K
cjn9ug03tg 9ssp7xih
27 Feb 24
Results of Operations and Financial Condition
4:45pm
424B5
c6tveed
27 Feb 24
Prospectus supplement for primary offering
4:40pm
8-K
EX-99.1
6sw2xt503 cugtc
8 Jan 24
Absci Corporation 2024 All Rights Reserved 42ND JP Morgan Healthcare Conference
7:08am
8-K
EX-99.1
i0xwm1j7jomhizrpo
20 Dec 23
Absci and PrecisionLife Announce Strategic R&D Partnership to Jointly Develop AI-Enabled Drug Pipeline
8:30am
8-K
EX-99.1
r3g3ty7t
4 Dec 23
Absci Announces Collaboration with AstraZeneca to Advance AI-Driven Oncology Candidate
7:31am
8-K
EX-99.2
fjedh
14 Nov 23
Absci Reports Business Updates and Third Quarter 2023 Financial and Operating Results
4:40pm
8-K
EX-99.1
mu99o gi8r0
14 Nov 23
Absci Reports Business Updates and Third Quarter 2023 Financial and Operating Results
4:40pm
8-K
EX-99.1
9p6vu
14 Aug 23
Absci Reports Business Updates and Second Quarter 2023 Financial and Operating Results
8:13am
424B5
6mmcmalrrmvqu
16 Jun 23
Prospectus supplement for primary offering
4:45pm
8-K
EX-99.1
b7qf1d 6kbcbp3
15 May 23
Absci Reports Business Updates and First Quarter 2023 Financial and Operating Results
4:08pm
ARS
kquefm
28 Apr 23
Annual report to shareholders
12:00am